Abstract
Candida albicans biofilms are difficult to eradicate because early adhesion and hyphal development promote surface colonization and antifungal tolerance. This study evaluated commercially obtained synthetic cinnamyl acetate (CA; ≥98%) as a defined antivirulence candidate against C. albicans ATCC 10231. CA showed reproducible antifungal and antibiofilm activity, with MIC = 125 ± 5 µg/mL and MBIC = 180 ± 7 µg/mL, and was the most active ester in the comparator screen. At 0.5× MBIC, CA reduced early adhesion by 39%, decreased the hyphal fraction from 0.74 to 0.21, and down-regulated the hypha-associated markers HWP1 and ALS3 while planktonic viability and SYTOX Green uptake remained near baseline. Exploratory docking was compatible with an adhesin-associated working hypothesis, but direct target engagement was not demonstrated. Overall, synthetic CA is best interpreted as a proof-of-concept anti-adhesion lead rather than a confirmed adhesin inhibitor or stand-alone fungicidal agent. These findings provide a defined experimental framework for future validation in additional Candida strains, epithelial co-culture models, and biochemical target-engagement assays.

This publication has 27 references indexed in Scilit: